Local expression of platelet-activating factor-acetylhydrolase reduces accumulation of oxidized lipoproteins and inhibits inflammation, shear stress-induced thrombosis, and neointima formation in balloon-injured carotid arteries in nonhyperlipidemic rabbits

Circulation. 2005 Jun 21;111(24):3302-9. doi: 10.1161/CIRCULATIONAHA.104.476242. Epub 2005 Jun 13.

Abstract

Background: Platelet-activating factor (PAF) and PAF-like phospholipids are inactivated by PAF-acetylhydrolase (PAF-AH). Using nonhyperlipidemic animals, we tested whether local expression of PAF-AH into injured arteries might induce antithrombotic and antiinflammatory effects.Method and Results- Balloon-injured rabbit carotid arteries were infected at the time of injury with an adenovirus expressing either human plasma PAF-AH (AdPAF-AH) or bacterial beta-galactosidase (AdLacZ) or infused with saline. Seven days later, shear stress-induced thrombosis was observed in all AdLacZ-infected and saline-infused arteries (controls) but eliminated in AdPAF-AH-treated contralateral arteries, even in the presence of epinephrine or an inhibitor of NO production. Injury-induced expression of tissue factor was also significantly suppressed. In AdPAF-AH-treated arteries compared with controls, the expressions of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 and macrophage infiltration were decreased by 66%, 66%, and 71%, respectively (P<0.01), and intimal area and intima/media ratio were decreased on day 21 by 43% and 52%, respectively (P<0.05). Within 1 week after injury, oxidized lipoproteins (OxLDL) had readily accumulated in the arterial wall. However, this was markedly reduced in the AdPAF-AH-treated arteries. No differences in the titers of autoantibodies to OxLDL or total cholesterol in blood were found between controls and AdPAF-AH-treated rabbits.

Conclusions: Our results show for the first time that OxLDL accumulates in arteries in nonhyperlipidemic animals within 1 week after injury and that local expression of PAF-AH reduces this accumulation and exerts antiinflammatory, antithrombotic, and antiproliferative effects without changing the plasma levels of PAF-AH activity or titers of autoantibodies to OxLDL.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Alkyl-2-acetylglycerophosphocholine Esterase / administration & dosage
  • 1-Alkyl-2-acetylglycerophosphocholine Esterase / genetics*
  • 1-Alkyl-2-acetylglycerophosphocholine Esterase / pharmacology
  • Animals
  • Animals, Genetically Modified
  • Anti-Inflammatory Agents / administration & dosage
  • Autoantibodies / analysis
  • Carotid Arteries / metabolism
  • Carotid Arteries / pathology
  • Carotid Artery Injuries / complications
  • Carotid Artery Injuries / therapy*
  • Catheterization / adverse effects
  • Cell Adhesion Molecules / analysis
  • Fibrinolytic Agents / administration & dosage
  • Humans
  • Inflammation / prevention & control*
  • Inflammation / therapy
  • Lipoproteins, LDL / drug effects
  • Lipoproteins, LDL / metabolism*
  • Macrophages / physiology
  • Rabbits
  • Stress, Mechanical
  • Thrombosis / etiology
  • Thrombosis / prevention & control*
  • Thrombosis / therapy
  • Transduction, Genetic
  • Tunica Intima / growth & development*

Substances

  • Anti-Inflammatory Agents
  • Autoantibodies
  • Cell Adhesion Molecules
  • Fibrinolytic Agents
  • Lipoproteins, LDL
  • oxidized low density lipoprotein
  • 1-Alkyl-2-acetylglycerophosphocholine Esterase